Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Johnson

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Neurology|June 1, 1996
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administrationO A Khan, Q Xia, C T Bever, et al.
Medical and Veterinary Entomology|January 13, 2016
Patterns of cryptic host specificity in duck lice based on molecular dataG C Escalante, A D Sweet, K G McCracken, et al.
Journal of Neuroimmunology|July 17, 1999
The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosisH Jiang, B Bielekova, H Okazaki, et al.
Annals of Neurology|May 1, 1977
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapyK H Rand, K P Johnson, L J Rubinstein, et al.
Molecular Ecology|September 17, 2009
Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowlK G McCracken, C P Barger, M Bulgarella, et al.
Archives of Neurology|December 1, 1986
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosisD L Camenga, K P Johnson, M Alter, et al.
Neurology|July 1, 1995
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, J A Cohen, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
Annals of Neurology|March 1, 1983
New diagnostic criteria for multiple sclerosis: guidelines for research protocolsC M Poser, D W Paty, L Scheinberg, et al.
Neurology|December 1, 1996
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trialC T Bever, P A Anderson, J Leslie, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Neurology|June 1, 1996
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administrationO A Khan, Q Xia, C T Bever, et al.
Medical and Veterinary Entomology|January 13, 2016
Patterns of cryptic host specificity in duck lice based on molecular dataG C Escalante, A D Sweet, K G McCracken, et al.
Journal of Neuroimmunology|July 17, 1999
The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosisH Jiang, B Bielekova, H Okazaki, et al.
Annals of Neurology|May 1, 1977
Adenine arabinoside in the treatment of progressive multifocal leukoencephalopathy: use of virus-containing cells in the urine to assess response to therapyK H Rand, K P Johnson, L J Rubinstein, et al.
Molecular Ecology|September 17, 2009
Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowlK G McCracken, C P Barger, M Bulgarella, et al.
Archives of Neurology|December 1, 1986
Systemic recombinant alpha-2 interferon therapy in relapsing multiple sclerosisD L Camenga, K P Johnson, M Alter, et al.
Neurology|July 1, 1995
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study GroupK P Johnson, B R Brooks, J A Cohen, et al.
Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.
Annals of Neurology|March 1, 1983
New diagnostic criteria for multiple sclerosis: guidelines for research protocolsC M Poser, D W Paty, L Scheinberg, et al.
Neurology|December 1, 1996
Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trialC T Bever, P A Anderson, J Leslie, et al.
Pageof 15